Engineered Bacillus subtilis as Oral Probiotics To Enhance Clearance of Blood Lactate.
- 2024-12-31
- ACS synthetic biology 14(1)
- Mengdi Yang
- Noah Hutchinson
- Ningyuan Ye
- Hania Timek
- Maria Jennings
- Jianing Yin
- Ming Guan
- Zongqi Wang
- Peiru Chen
- Shaobo Yang
- Justin D Crane
- Ke Zhang
- Xuesong He
- Jiahe Li
- PubMed: 39739838
- DOI: 10.1021/acssynbio.4c00399
- Low evidence
- Animal Study
oral administration of engineered B. subtilis spores to the gut of mice reduced the level of blood lactate in two different mouse models involving exogenous challenge or pharmacologic perturbation
- Effect
- Beneficial
- Effect size
- Moderate